Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Twice daily topical application |
|
| 2 | Placebo Comparator | Twice daily topical application |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tetrix | Device | Twice daily topical application |
| |
| Tetrix |
| Measure | Description | Time Frame |
|---|---|---|
| Prevention of delayed bype hypersensitivity reaction following application of antigen | up to 96 hours after antigen application |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joseph Fowler, MD | Dermatology Specialists | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dermatolgoy Specialists, LLC | Louisville | Kentucky | 40202 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
Twice daily topical application |
|